Due to a limited supply, we are unable to accept phone calls to schedule COVID-19 vaccinations.
For the most up-to-date information, please check our COVID-19 Vaccination Website.

Additional Coronavirus Updates >

MENU

Cancer Diagnostics and Risk Assessment

Technology Transfer Contacts

Inna Khartchenko, MS, MBA
Director, Technology Transfer
215-214-3989
Inna.Khartchenko@fccc.edu
Natalia Shalginskikh, PhD
Licensing Associate,
Technology Transfer
267-963-7121
Natalia.Shalginskikh@fccc.edu
Tatiana Venkova, PhD
Licensing Associate,
Technology Transfer
215-214-3909;
Tatiana.Venkova@fccc.edu

(technologies available for licensing)

Note: Links to Patents may require a browser newer than Internet Explorer 9, such as Chrome, Safari, Firefox, Edge, or Internet Explorer 11

TECH ID	TITLE	LEAD INVENTOR	CONTACT
07-43	Biomarkers for Early Pancreatic Cancer Detection and Treatment Patent No. US8609437B2; Summary	Anthony Yeung	Inna Khartchenko
256-JT	Novel Diagnostic and Prognostic Marker for Malignant Mesothelioma Patent No. US10344333B2; Summary	Joseph Testa	Tatiana Venkova
305-MC	Estrogen Metabolite Levels and CYP1B1 Polymorphisms in Lung Cancer Diagnosis, Prognosis, and Risk Assessment Published Application No.US20190180877A1	Margie Clapper	Natalia Shalginskikh
312-GE	Novel Diagnostic Method for Predisposition to Colorectal Cancer Patent No. US9157124B2; Summary	Greg Enders	Inna Khartchenko
364-EP	Novel Screening Biomarkers for Muscle Invasive Bladder Cancer Response to Chemotherapy Published Application No.US20150184251A1; Summary	Elizabeth Plimack	Natalia Shalginskikh
394-EG	Novel Biomarkers for Prognosis and Diagnosis of Prostate Cancer Published Application No.WO2017049023A1; Summary	Erica Golemis	Tatiana Venkova
396-EC	Novel Biomarker For Risk Assessment And Treatment Evaluation For Cancers With Fibrosis Published Application No.WO2018005355; Summary	Edna Cukierman	Natalia Shalginskikh
426-SA	Methods For Diagnosis And Treatment Of Patients Having Solid Tumors Published Application No.WO2018152154A1; Summary	Sanjeevani Arora	Tatiana Venkova
431-WE	High EGFR Somatic Mutation Frequency Targeting the TK Domain in Colorectal Cancer Patients with Microsatellite Instability (MSI) Published Application No.WO2018157032A1; Summary	Wafik El-Deiry	Tatiana Venkova
443-JFB	Novel Cancer Prognostic based on MHC-I Genotype and Presentability Published Application No.WO2019005764A1; Summary	Joan Font-Burgada	Tatiana Venkova
461-PA	Urinary DNA Detection for Monitoring of Urothelial Cancer Published Application No.WO2019222325A1; Summary	Philip Abbosh	Natalia Shalginskikh
516-ZY	Applications of exosomes in the diagnosis of brain tumors Patent pending	Zeng-Jie Yang	Natalia Shalginskikh
522-MC	Estrogen Metabolite Levels and EGFR Mutations in Lung Cancer Risk Stratification and Treatment Patent pending	Margie Clapper	Natalia Shalginskikh